45 results on '"Vozobulová V"'
Search Results
2. No benefit of autologous stem cell transplantation as consolidation for high and high-intermediate risk diffuse large B-cell lymphoma in 1.CR after R-CHOP therapy - A single-centre experience: R1286
3. Reduced-intensity transplantation in patients older than 60 years of age with high-risk or advanced acute myeloid leukaemia - single-centre experience
4. Inefficiency of high-dose G-CSF alone as second mobilization regimen in fludarabin-cyclophosphamide-treated CLL patients who failed to mobilize after chemotherapy and G-CSF
5. Epstein-Barr virus-associated B-cell lymphoproliferative disorder in CLL patients after treatment with fludarabine and cyclophosphamide followed by high-dose chemotherapy with autologous stem cell transplantation
6. Autologous CD34+ cells transplantation after FAMP treatment in a patient with CLL and persisting AIHA: complete remission of lymphoma with control of autoimmune complications
7. P075 Characteristics of patients with therapy-related myelodysplastic syndrome
8. Frontline transplantation of autologous CD34+ selected blood cells for advanced mantle cell lymphoma: no evidence of long-term cure: a single centre experience
9. 180 - Is the Diagnosis of Patients with Del(5Q) and Trisomy 8 Different, when Found in Unrelated Clones or in One Clone?
10. Doporučení ČHS pro diagnostiku a léčbu imunitní trombocytopenie (ITP).
11. Jsme oprávněni řadit nemocné s dvěma samostatnými buněčnými klony a to s delecí 5q a s trizomií 8 jako podskupinu myelodysplastického syndromu typu 5q- syndromu?
12. 164 Promising cyclosporin a therapy for myelodysplastic syndrome
13. 20 Incidence of cancer and body iron stores in sideroblastc anemia
14. První zkušenosti České MDS skupiny s terapií 5-azacytidinem u nemocných s myelodysplastickým syndromem s vyšším rizikem (IPSS střední 2 a vysoké riziko), akutní myeloidní leukemií do 30 % myeloblastů a chronickou myelomonocytární leukemií II
15. 301 Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q- MDS (IPSS low and Intermediate-1)
16. 124 Are we warranted to include patients with del 5q and trisomy 8 into the 5q minus syndrome?
17. Spontánní remise akutní myeloidní leukemie -- klinické případy jednoho centra.
18. Autologous CD34+ cells transplantation after FAMP treatment in a patient with CLL and persisting AIHA: complete remission of lymphoma with control of autoimmune complications.
19. Therapy-related myelodysplastic syndrome: A retrospective analysis of data from the Czech Working MDS group registry | Sekundární myelodysplastický syndrom: Retrospektivní analýza dat z registru České pracovní MDS skupiny
20. Mixed myelodysplastic and myeloproliferative syndromes | Smísené myelodysplastické a myeloproliferativní syndromy
21. Imatinib (Glivec®) in the treatment of patients with accelerated phase of chronic myelogenous leukaemia and Ph-positive acute lympho-blastic leukaemia,Imatinib (Glivec®) v léčbě nemocných s akcelerovanou fází chronické myeloidní leukémie a Ph pozitivní akutní lymfoblastické leukémie
22. The results of the of patiens with essentials thrombocythemia and other myeloproliferation-related thrombocythemia - A report of patients treated with Thromboreductin®,Výsledky léčby nemocných s esenciá lní trombocytemií a dalšími myeloproliferacemi provázenými trombocytemií - Zpráva z registru pacientů léčených thromboreductinem®
23. Analysis of myelodysplastic syndrome patients with deletion of lone arm of chromosome 5 followed up by the Czech MDS Working Group. Significance for the diagnostic and prognostic assessment | Analýza nemocných s myelodysplastickým syndromem (MDS) s delecí dlouhého ramene 5. chromozomu del(5q), sledovaných Českou MDS pracovní skupinou. Význam pro diagnostické zařazení a určení prognózy
24. Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin® till the end of 2006,Esenciální trombocytemie a další myeloproliferace s trombocytemií v údajích registru pacientů léčených Thromboreductinem® do konce roku 2006
25. What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocytopenia, and what can be the predictive sign of the risk of thrombosis in such patients - A report from the registry of patients treated by Thromboreductine®,Jak léčíme nemocné s esenciální trombocytemii a dalšími myeloproliferacemi provázený mi tromboqrtemií a co může být prediktivní známkou rizika trombózy u těchto nemocných - Zpráva z registru pacientů léčených Thromboreductinem®
26. Successful collection of peripheral hematopoietic stem cells in a patient with nilotinib treated chronic myeloid leukemia,Úspěšný odběr periferních krvetvorných buněk u pacientky s chronickou myeloidní leukemií léčenou nilotinibem. Kazuistika
27. Radiotherapy indications in patients with hematological malignancies during the five years course of modernized center of oncology and radiotherapy clinic in Pilsen,Indikace radioterapie u pacientů s hematologickými malignitami v průběhu pěti let provozu modernizovaného centra Onkologické a radioterapeutické kliniky v Plzni
28. Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR,Anagrelid v léčbě esenciální trombocytemie a dalších myeloproliferací s trombocytemií sledovaných v registru pacientů v ČR
29. Discontinuation of biological therapy with tyrosine kinase inhibitors in chronic myeloid leukemia patients,Koncept preřušení biologické léčby tyrozinkinázovými inhibitory u chronické myeloidní leukemie
30. Indikace radioterapie u pacientů s hematologickými malignitami v průběhu pěti let provozu modernizovaného centra Onkologické a radioterapeutické kliniky v Plzni.
31. Frontline transplantation of autologous CD34+ selected blood cells for advanced mantle cell lymphoma: no evidence of long-term cure: a single centre experience.
32. [Radiotherapy Indications in Patients with Hematological Malignancies During the Five Years Course of Modernized Center of Oncology and Radiotherapy Clinic in Pilsen].
33. [Spontaneous remission of acute myeloid leukemia - a single center case reports].
34. [Angioimmunoblastic T-cell lymphoma as a very poor-prognosis malignancy--a single centre experience].
35. [The results of patients with essentials thrombocythemia and other myeloproliferation-related thrombocythemia--a report of patients treated with Thromboreductin].
36. [What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine].
37. [Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin till the end of 2006].
38. [Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR].
39. [Allogenic transplantation of bone marrow in patients with chronic myeloid leukemia 1991-1995 and 1996-1998. Experience at the Hematology-Oncology Clinic of the University Hospital in Plzen].
40. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow.
41. [Mixed myelodysplastic and myeloproliferative syndromes].
42. Cyclophosphamide 3 g/m2 and G-CSF is an effective and safe outpatient-based PBSC mobilising regimen: a single centre experience.
43. [Monocytosis and myelomonocytic dysplasia in myelodysplastic syndrome].
44. [Treatment of myelodysplastic syndrome using continual subcutaneous infusion of low doses of cytosine arabinoside].
45. [Treatment of medium and highly malignant non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisone and bleomycin (protocol MACOP-B)].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.